Log in

TSE:EDTSpectral Medical Stock Price, Forecast & News

C$0.56
+0.01 (+1.82 %)
(As of 07/3/2020 06:08 AM ET)
Add
Compare
Today's Range
C$0.54
Now: C$0.56
C$0.56
50-Day Range
C$0.55
MA: C$0.62
C$0.69
52-Week Range
C$0.36
Now: C$0.56
C$0.85
Volume18,008 shs
Average Volume92,699 shs
Market CapitalizationC$132.50 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Spectral Medical Inc. focuses on the development and commercialization of treatment for septic shock in North America. The company markets Endotoxin Activity Assay, a rapid diagnostic test for the detection of components of gram negative bacterial cell wall in Europe and Canada; and Toraymyxin, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream in Europe, Canada, and Japan. It also develops, produces, and markets recombinant proteins, antibodies, and calibrators for use in the research and development, as well as markets products that are manufactured by other diagnostic companies; and develops continuous renal replacement therapy, an open platform for other hemoperfusion cartridges. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was founded in 1991 and is headquartered in Toronto, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.61 out of 5 stars


Industry, Sector and Symbol

Industry Medical Laboratories & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-416-6263233

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$2.95 million
Cash FlowC$0.03 per share
Book ValueC$0.00 per share

Profitability

Miscellaneous

Employees18
Market CapC$132.50 million
Next Earnings Date8/20/2020 (Estimated)
OptionableNot Optionable

Receive EDT News and Ratings via Email

Sign-up to receive the latest news and ratings for EDT and its competitors with MarketBeat's FREE daily newsletter.

Spectral Medical (TSE:EDT) Frequently Asked Questions

How has Spectral Medical's stock been impacted by COVID-19 (Coronavirus)?

Spectral Medical's stock was trading at C$0.57 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, EDT shares have decreased by 1.8% and is now trading at C$0.56. View which stocks have been most impacted by Coronavirus.

When is Spectral Medical's next earnings date?

Spectral Medical is scheduled to release its next quarterly earnings announcement on Thursday, August 20th 2020. View our earnings forecast for Spectral Medical.

How were Spectral Medical's earnings last quarter?

Spectral Medical Inc (TSE:EDT) announced its earnings results on Friday, May, 15th. The company reported ($0.02) earnings per share (EPS) for the quarter. The company had revenue of $0.63 million for the quarter. View Spectral Medical's earnings history.

Has Spectral Medical been receiving favorable news coverage?

Media headlines about EDT stock have been trending somewhat negative recently, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Spectral Medical earned a news impact score of -1.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news about Spectral Medical.

Who are some of Spectral Medical's key competitors?

What other stocks do shareholders of Spectral Medical own?

Who are Spectral Medical's key executives?

Spectral Medical's management team includes the following people:
  • Dr. Paul M. Walker, Pres, CEO & Director (Age 70)
  • Dr. Gualtiero Guadagni, VP of Sales & Marketing
  • Mr. Richard Wieland, Interim Chief Financial Officer

What is Spectral Medical's stock symbol?

Spectral Medical trades on the Toronto Stock Exchange (TSX) under the ticker symbol "EDT."

How do I buy shares of Spectral Medical?

Shares of EDT and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Spectral Medical's stock price today?

One share of EDT stock can currently be purchased for approximately C$0.56.

How big of a company is Spectral Medical?

Spectral Medical has a market capitalization of C$132.50 million and generates C$2.95 million in revenue each year. Spectral Medical employs 18 workers across the globe.

What is Spectral Medical's official website?

The official website for Spectral Medical is www.spectraldx.com.

How can I contact Spectral Medical?

Spectral Medical's mailing address is 135 the West Mall Unit 2, ETOBICOKE, ON M9C 1C2, Canada. The company can be reached via phone at +1-416-6263233.

This page was last updated on 7/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.